Navigation Links
Surface Logix Achieves Objectives With SLx-4090 in Phase 2a Clinical Trial
Date:1/29/2008

BOSTON, Jan. 29 /PRNewswire/ -- Surface Logix today announced positive results in the Company's Phase 2a clinical trial of SLx-4090 in dyslipidemia (high cholesterol and triglyceride levels in the bloodstream). The randomized, double-blind, placebo-controlled Phase 2a study in 24 patients with dyslipidemia demonstrated that SLx-4090 caused clinically significant reductions in postprandial triglycerides and LDL-cholesterol and was well tolerated. The trial was designed to examine the safety, tolerability, pharmacokinetics and effect on lipid profiles in patients administered repeat oral doses of SLx-4090 either three times daily or once daily for 14 days. The Company intends to initiate a Phase 2b study of SLx-4090 in dyslipidemia in the third quarter of 2008.

"The Phase 2a trial showed that SLx-4090 was efficacious and well tolerated in patients," said Dr. Warwick Tong, Senior Vice President of Commercial Development of Surface Logix. "We were particularly pleased to see, in both dosing regimens, drops not only in postprandial triglycerides but also in fasting LDL-cholesterol levels in just 14 days. Importantly, SLx-4090's adverse event profile was indistinguishable from that of placebo. We saw no effect on liver function tests, which is consistent with the compound being undetectable in the plasma, and no impact on bowel habit."

"We were also pleased to see clinically significant weight loss in patients who received SLx-4090," added Dr. William Prince, Chief Development Officer of Surface Logix. "We attribute this to the decreased uptake of triglycerides, a significant source of calories in the diet. Given that obesity is a major and growing health concern, we believe SLx-4090's potential to cause weight loss represents a significant opportunity for therapeutic intervention."

SLx-4090 is a novel, oral, non-systemically available inhibitor of microsomal triglyceride transfer protein (MTP) that acts by blocking the formation of particles k
'/>"/>

SOURCE Surface Logix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Decision Biomarkers Awarded U.S. Patent for Protein Array Surface Chemistry
2. Sureshield Coatings Company Established to Market Industry-Leading Portfolio of Advanced Coatings for Metal Surfaces
3. Hill-Rom Introduces New Wound Therapy Surface With Innovative Safety and Treatment Features
4. Physicists pin down spin of surface atoms
5. NanoLogixs Hydrogen-From-Waste Technology at Welchs Foods Featured on Environmental Radio Program
6. NanoLogix, Inc. Makes Stock Pick List
7. FDA Grants Resverlogix Approval to Commence a Phase 1 Clinical Trial for RVX-208
8. Resverlogix Honoured with World Economic Forum Technology Pioneer Award
9. ForceLogix, Innovex Win Sales Operational Performance Award
10. NanoLogix Inc. Sets Date for Annual Shareholder Meeting and Provides Shareholder Update
11. Resverlogix is Presenting at IAS HDL Workshop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2015)... CA (PRWEB) April 23, 2015 Athena ... personal development of executive women in San Diego’s technology ... the 17th Annual Pinnacle Awards at their Gala on ... Hyatt Hotel. Register now at http://athenasd.org/events/ , ... support the Athena San Diego vision of fostering networking, ...
(Date:4/23/2015)... , April 23, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... report its first quarter 2015 results before the Nasdaq ... then host a live conference call and webcast to discuss ... morning, April 30, 2015 at 8:00 a.m. Eastern Time ... the live conference call by dialing 866-952-1906 (US) or ...
(Date:4/23/2015)... Prospects for Leading Companies in ... Details   We predict the global healthcare ... in 2015 and will grow at a CAGR of 6.3% ... around the world and increasing functional requirements for healthcare packaging ... global healthcare packaging market. A global ageing population, ...
(Date:4/23/2015)... April 23, 2015 /PRNewswire/ - Crystal Research Associates, LLC ... Overview ® (EIO) on Aeterna Zentaris Inc. (NASDAQ: ... available on Crystal Research Associates, website at ... website at www.aezsinc.com . Aeterna Zentaris ... biopharmaceutical company in oncology, endocrinology, and women,s health. With ...
Breaking Biology Technology:Athena Pinnacle Awards to Honor Executives, Corporations and Educators Working to Promote Women Leaders 2Neurocrine Biosciences Announces Conference Call and Webcast to Report First Quarter 2015 Results 2Healthcare Packaging Market Forecast 2015-2025 2Healthcare Packaging Market Forecast 2015-2025 3Healthcare Packaging Market Forecast 2015-2025 4Healthcare Packaging Market Forecast 2015-2025 5Healthcare Packaging Market Forecast 2015-2025 6Healthcare Packaging Market Forecast 2015-2025 7Healthcare Packaging Market Forecast 2015-2025 8Healthcare Packaging Market Forecast 2015-2025 9Healthcare Packaging Market Forecast 2015-2025 10Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on Aeterna Zentaris Inc. 2Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on Aeterna Zentaris Inc. 3
... Hospital (TSH),Canada,s largest urban community hospital, has selected ... physicians. The,implementation of Chyma(TM) for their team of ... ER departments at the two hospital campuses and ... medicine., "Chyma(TM) reflects the commitment of the ...
... Mass., June 2 RainDance Technologies, Inc.,a ... health and,disease research, today announced the appointment ... effective immediately., "As RainDance solutions enter ... to establish our manufacturing and financial capabilities,",said ...
... announced the,release of a new and exciting module ... experience with different techniques and,alternative approaches to the ... The GYN module is the latest addition to ... Mentor, the world,s most advanced,laparoscopic surgery simulator. The ...
Cached Biology Technology:Canada's Largest Urban Community Hospital Chooses Chyma(TM) On-Call Physician Scheduling Technology 2RainDance Appoints Kelly Chief Operating Officer 2Simbionix Takes Non-Invasive GYN Surgical Training to the Next Level 2
(Date:3/23/2015)... 2015 SoundView Technology Group issues a new research ... ) Wocket smart wallet. SoundView was one of the selected user ... with the Wocket in multiple scenarios and outlets. ... other retailers, making both debit and credit card payments.  ... "If the company meets their plans in 2015, it would ...
(Date:3/20/2015)... DUBLIN , Mar. 20, 2015 Research ... announced the addition of the "India Sensors ... their offering. The sensor market is ... through 2020 Consumer electronics, automotive, industrial ... for sensors in the country. In addition, adoption ...
(Date:3/19/2015)... March 19, 2015  NXT-ID, Inc. (NASDAQ: NXTD ... on the growing mobile commerce market, announces its biometric payment ... clip that aired this week on Washington DC,s ... In a segment "The Next Great Thing", host ... way to pay, and ,a really big breakthrough in mobile ...
Breaking Biology News(10 mins):Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3
... TAMPA, Fla. (Nov. 19, 2012) In three studies published in ... of the National Academy of Inventors , innovators unveil creative ... of energy, and change our lives. Untapped energy in ... and in Florida,s ocean waves can be captured and used, said ...
... has applied for a patent for a genetically-engineered vaccine strategy ... body structures that are the first sites of contact with ... last a lifetime, the vaccine will lead to the continual ... system. Another feature of the vaccine system is that it ...
... with histonesthe proteins that package DNAregulate many fundamental cell activities ... or blood cells becoming leukemic. These interactions are governed by ... chemically modify histones signaling them to clamp down tighter on ... expressed. In the November 19, 2012, online ...
Cached Biology News:New energy technologies promise brighter future 2New energy technologies promise brighter future 3Texas Biomed files patent for a novel HIV vaccine strategy 2Fruit fly studies guide investigators to misregulated mechanism in human cancers 2Fruit fly studies guide investigators to misregulated mechanism in human cancers 3
Edited by Benjamin Lewin (1997) • This book gives an integrated account of the structure and function of genes in both prokaryotic organisms and is thoroughly up to date with the latest thinking...
... Clone/PAD: 3F10B10. Immunogen: Synthetic ... region of JAB1 (Jun activation ... Specificity: Specific for the JAB1 ... controls: 293T Jurkat cell lysates). ...
Ready-to-use solution....
...
Biology Products: